HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...
Longeveron Inc. (NASDAQ:LGVN) reported on September 16 that ELPIS II, its randomized Phase 2b trial in 40 infants with hypoplastic left heart syndrome, missed its primary efficacy endpoint. The study ...
Background Antiretroviral therapy (ART)-treated people with HIV (PWH) have increased risk of heart failure with preserved ...
Researchers found that urolithin A improved relaxation in engineered human heart tissue and reduced several hallmarks of heart failure in laboratory models. Credit: Shutterstock A compound produced in ...
Indiana University researchers have found that administering intravenous dexrazoxane before, during and after reopening a blocked coronary artery in heart attack patients reduced ...
Heart failure is a heterogeneous syndrome. Approximately 30–50% of patients with heart failure have normal or near normal left ventricle function. Several epidemiological studies confirm that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results